AU2021240417A1 - Forskolin-inducible promoters and hypoxia-inducible promoters - Google Patents
Forskolin-inducible promoters and hypoxia-inducible promoters Download PDFInfo
- Publication number
- AU2021240417A1 AU2021240417A1 AU2021240417A AU2021240417A AU2021240417A1 AU 2021240417 A1 AU2021240417 A1 AU 2021240417A1 AU 2021240417 A AU2021240417 A AU 2021240417A AU 2021240417 A AU2021240417 A AU 2021240417A AU 2021240417 A1 AU2021240417 A1 AU 2021240417A1
- Authority
- AU
- Australia
- Prior art keywords
- seq
- acgt
- tca
- tga
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
- C12N2750/14152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063000155P | 2020-03-26 | 2020-03-26 | |
| US63/000,155 | 2020-03-26 | ||
| US202063010330P | 2020-04-15 | 2020-04-15 | |
| GB2005475.5 | 2020-04-15 | ||
| GBGB2005473.0A GB202005473D0 (en) | 2020-04-15 | 2020-04-15 | Forskolin-inducible promoters |
| GBGB2005475.5A GB202005475D0 (en) | 2020-04-15 | 2020-04-15 | Hypoxia-inducible promoters |
| GB2005473.0 | 2020-04-15 | ||
| US63/010,330 | 2020-04-15 | ||
| GB2101972.4 | 2021-02-12 | ||
| GBGB2101969.0A GB202101969D0 (en) | 2021-02-12 | 2021-02-12 | Hypoxia inducible promoters |
| GBGB2101972.4A GB202101972D0 (en) | 2021-02-12 | 2021-02-12 | Forskolin inducible promoters |
| GB2101969.0 | 2021-02-12 | ||
| PCT/GB2021/050743 WO2021191628A1 (en) | 2020-03-26 | 2021-03-26 | Forskolin-inducible promoters and hypoxia-inducible promoters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2021240417A1 true AU2021240417A1 (en) | 2022-10-20 |
Family
ID=77890128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021240417A Pending AU2021240417A1 (en) | 2020-03-26 | 2021-03-26 | Forskolin-inducible promoters and hypoxia-inducible promoters |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230374526A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4127180A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023519925A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115698300A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021240417A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3171636A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021191628A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025015211A1 (en) * | 2023-07-12 | 2025-01-16 | Georgia Tech Research Corporation | Synthetic genetic constructs that induce gene expression in response to tumor-specific metabolic alterations |
| WO2025090555A1 (en) * | 2023-10-23 | 2025-05-01 | University Of Southern California | Ultrasound-controlled car t with sensitive evolved promoter and feedback integration and uses thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| GB9206874D0 (en) * | 1992-03-30 | 1992-05-13 | Connaught Lab | Generation of improved inducible mammalian expression vectors |
| IT1258959B (it) | 1992-06-09 | 1996-03-11 | Impianto a moduli mobili per lo sviluppo e la produzione di prodotti biotecnologici su scala pilota | |
| EP1136567A1 (en) * | 2000-03-24 | 2001-09-26 | Advanced Array Technologies S.A. | Method and kit for the screening, the detection and /or the quantification of transcriptional factors |
| US7402406B2 (en) * | 2001-10-31 | 2008-07-22 | Astellas Pharma Inc. | Methods of evaluating phosphatase inhibitors |
| US20060127371A1 (en) * | 2002-11-25 | 2006-06-15 | Peppelenbosch Maikel P | ASB transcription repressor proteins and nucleic acids and their application in expansion of stem cells |
| JP2007520820A (ja) | 2004-02-03 | 2007-07-26 | エクセラーエックス, エルエルシー | 製造のためのシステムおよび方法 |
| CN101001945B (zh) | 2004-06-04 | 2012-02-08 | 艾克塞勒雷克斯公司 | 一次性生物反应器系统及方法 |
| US20080206817A1 (en) | 2004-12-07 | 2008-08-28 | Johann Brass | Rhamnose Promoter Expression System |
| US20090305626A1 (en) | 2005-12-05 | 2009-12-10 | Hope Ernest G | Prevalidated, modular good manufacturing practice-compliant facility |
| EP2207796A2 (en) * | 2007-11-02 | 2010-07-21 | Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg | Polypeptides involved in neuronal regeneration-associated gene expression |
| US8815779B2 (en) * | 2009-09-16 | 2014-08-26 | SwitchGear Genomics, Inc. | Transcription biomarkers of biological responses and methods |
| WO2011139708A2 (en) | 2010-04-26 | 2011-11-10 | Toyota Motor Engineering & Manufacturing North America, Inc. | Improved hydrogen release from complex metal hydrides by solvation in ionic liquids |
| US10371394B2 (en) | 2010-09-20 | 2019-08-06 | Biologics Modular Llc | Mobile, modular cleanroom facility |
| US9388373B2 (en) | 2011-03-08 | 2016-07-12 | University Of Maryland Baltimore County | Microscale bioprocessing system and method for protein manufacturing |
| KR102128957B1 (ko) | 2011-10-07 | 2020-07-02 | 론자 리미티드 | 조절가능한 프로모터 |
| MY172311A (en) * | 2012-08-02 | 2019-11-21 | Univ Putra Malaysia | Hypoxia inducible factor (hif) activity reporter cell line |
| AU2018215537B2 (en) * | 2017-02-03 | 2023-11-09 | Manus Bio, Inc. | Metabolic engineering for microbial production of terpenoid products |
| CN110582574A (zh) * | 2017-03-13 | 2019-12-17 | 麻省理工学院 | 合成启动子 |
| CN107523588B (zh) * | 2017-08-18 | 2020-08-07 | 深圳大学 | 一种四环素慢病毒诱导表达载体及其建立方法和应用 |
| GB201713545D0 (en) * | 2017-08-23 | 2017-10-04 | Synpromics Ltd | Expression control using a regulatable intron |
| WO2021158658A1 (en) * | 2020-02-04 | 2021-08-12 | The Board Of Trustees Of The Leland Stanford Junior University | Split crispr-cas for biological signal integration |
-
2021
- 2021-03-26 CA CA3171636A patent/CA3171636A1/en active Pending
- 2021-03-26 EP EP21716825.1A patent/EP4127180A1/en active Pending
- 2021-03-26 JP JP2022558590A patent/JP2023519925A/ja active Pending
- 2021-03-26 CN CN202180037885.0A patent/CN115698300A/zh active Pending
- 2021-03-26 US US17/913,728 patent/US20230374526A1/en active Pending
- 2021-03-26 WO PCT/GB2021/050743 patent/WO2021191628A1/en not_active Ceased
- 2021-03-26 AU AU2021240417A patent/AU2021240417A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3171636A1 (en) | 2021-09-30 |
| EP4127180A1 (en) | 2023-02-08 |
| CN115698300A (zh) | 2023-02-03 |
| JP2023519925A (ja) | 2023-05-15 |
| WO2021191628A1 (en) | 2021-09-30 |
| US20230374526A1 (en) | 2023-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109295053B (zh) | 通过诱导剪接位点碱基突变或多聚嘧啶区碱基置换调控rna剪接的方法 | |
| JP2023081927A (ja) | アデノ随伴ウイルスを生産するための哺乳動物細胞 | |
| US12472269B2 (en) | Liver-specific inducible promoters and methods of use thereof | |
| JP2023522020A (ja) | 顔面肩甲上腕型筋ジストロフィーのためのcrispr阻害 | |
| WO2022232442A2 (en) | Multiplex crispr/cas9-mediated target gene activation system | |
| US20230374526A1 (en) | Forskolin-inducible promoters and hypoxia-inducible promoters | |
| US20250302992A1 (en) | Polycistronic Expression of Gut Peptides | |
| US20230167458A1 (en) | Forskolin-inducible promoters and hypoxia-inducible promoters | |
| Niessen et al. | Novel diabetes mellitus treatment: mature canine insulin production by canine striated muscle through gene therapy | |
| EP4722361A1 (en) | Vector used for preparing circular rna and method | |
| RU2834035C1 (ru) | Нуклеиновая кислота, содержащая последовательность гена PRDM16, предназначенная для снижения массы тела млекопитающего, экспрессионный вектор для экспрессии в клетках млекопитающего, способ его доставки и способ снижения массы тела млекопитающего | |
| US20260002151A1 (en) | Compositions and methods for the modification and regulation of liver gene expression | |
| US20260041789A1 (en) | Gene therapy DNA vector based on gene therapy DNA vector GDTT1.8NAS12 carrying the therapeutic gene selected from the group of DDC, IL10, IL13, IFNB1, TNFRSF4, TNFSF10, BCL2, HGF, and IL-2 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain JM110-NAS/GDTT1.8NAS12-DDC, or Escherichia coli strain JM110-NAS/GDTT1.8NAS12-IL10, or Escherichia coli strain JM110-NAS/GDTT1.8NAS12-IL13, or Escherichia coli strain JM110-NAS/GDTT1. | |
| WO2025084955A1 (ru) | Нуклеиновая кислота для снижения массы тела млекопитающего | |
| HK40056629A (en) | Liver-specific inducible promoters and methods of use thereof | |
| HK40056629B (en) | Liver-specific inducible promoters and methods of use thereof | |
| CN121358865A (zh) | 肝脏特异性调控核酸序列 | |
| US20140031417A1 (en) | Skeletal muscle-specific enhancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HB | Alteration of name in register |
Owner name: ASKBIO INC. Free format text: FORMER NAME(S): ASKLEPIOS BIOPHARMACEUTICAL, INC. |